Silvio E Inzucchi, MD

Professor of Medicine (Endocrinology); Clinical Chief, Endocrinology; Director, Inpatient Diabetes Management Team, Endocrinology; Clinical Director, Endocrinology; Director, Yale Diabetes Center; Program Director, Endocrinology & Metabolism Fellowship, Endocrinology; Director, Yale Affiliated Hospitals Program, Internal Medicine

Departments & Organizations

Internal Medicine: Diabetes Research Center | Endocrinology: Diabetes Center; Pituitary Program

Yale Cancer Center: Endocrine Cancers Program

Yale Medicine

Office of Cooperative Research

Biography

Dr. Inzucchi received his undergraduate degree from Fordham University in the Bronx, NY and his M.D. degree from Harvard Medical School in Boston, MA. He completed his internship and residency in Internal Medicine and his post-doctoral Fellowship in Endocrinology and Metabolism at Yale-New Haven Hospital, in New Haven, CT. Dr. Inzucchi has authored or co-authored over 250 manuscripts, monographs, textbook chapters, and abstracts, and has lectured at a national and international level on a wide variety of endocrine topics. Dr. Inzucchi has a large academic clinical practice involving a broad spectrum of patients with endocrine diseases. His specific
clinical interests include diabetes as well as pituitary/adrenal disorders. His current research involves studies on the link between type 2 diabetes, insulin resistance, and cardiovascular complications; management of hyperglycemia in the hospital; and diagnostic criteria for diabetes and related conditions.

Education & Training

MD Harvard University (1985)
BS Fordham University (1981)
Postdoctoral Fellow Yale-New Haven Hospital
Resident Yale-New Haven Hospital
Intern Yale-New Haven Hospital
Board Certification AB of Internal Medicine, Internal Medicine (1988)

Honors & Recognition

  • Connecticut Magazine Top Docs 2016Connecticut Magazine (2016)

  • Leffell Award for Clinical ExcellenceYale Medical Group (2015)

  • Connecticut Magazine Top Docs 2015Connecticut Magazine (2015)

  • John D. Thompson Award for Excellence in the Delivery of Healthcare Through the Use of DataConnecticut Hospital Association (2010)

  • Women’s Health Magazine’s “Top Doctors for Women” (Endocrinologists) (2008)

  • New York Magazine’s Best Doctors (Endocrinologists), New York Metro Area (2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017)

  • Joseph Zaccagnino Patient Safety & Quality AwardYale-New Haven Hospital (2007)

  • Best Doctors in America (2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017)

  • Pfizer Visiting Professor in DiabetesState University of New York at Stony Brook (2001)

  • Teacher of the Year AwardYale-New Haven Hospital Internal Medical Residency Program (1998)

  • Samuel Kushlan AwardYale-New Haven Hospital (1986)

  • Honors in PediatricsHarvard Medical School (1984)

  • Honors in MedicineHarvard University (1983)

  • Summer Research AwardHarvard University (1982)

  • Phi Beta Kappa, tau chapterFordham University (1981)

Professional Service

  • Daiichi-Sankyo (2016 - 2017) Chair of Steering Committee, DS8500-A-U202 Trial

  • University of Pittsburgh (2016 - Present) Data Monitoring Committee, TAME-PKD: Trial of Administration of Metformin-Autosomal Dominant Polycystic Kidney Disease/PRO15060422

  • Endocrine (2015 - Present) Editorial Board

  • Cardiovascular Endocrinology (2015 - Present) Editorial Board

  • Saint Luke's Mid America Heart Institute (2015 - Present) Steering Committee, DEFINE HF Trial

  • American College of Cardiology (2014 - 2015) NCDR (National Cardiovascular Data Registry) PINNACLE Registry Expert Dataset Panel Work Group

  • Clinical Diabetes and Endocrinology (2014 - Present) Editorial Board

  • Nutrition, Metabolism and Cardiovascular Disease (2014 - Present) Editorial Board

  • American College of Cardiology (2014 - Present) Chair of the Research and Publications Subcommittee, NCDR Diabetes Collaborative Registry

  • Brigham & Women’s Hospital/Harvard Medical School (2014 - Present) Steering Committee, CAMELLIA-TIMI 61

  • Lexicon Pharmaceuticals (2014 - Present) Steering Committee, LX4211 Program

  • Novo Nordisk (2013 - 2016) Data Monitoring Committee, SUSTAIN 6 Trial

  • Merck Research Laboratories (2013 - 2016) Scientific Advisory Committee, MK-3102 Phase III program

  • Florida Hospital Diabetes Institute (2013 - Present) External Advisory Committee, Inpatient Diabetes Program

  • Gilead Sciences, Inc (2012 - 2014) Chair of Data Safety Monitoring Board, Ranolazine in Type 2 Diabetes Mellitus Phase 3 Program

  • Endocrine Society (2012) Endocrine Board Review Committee

  • Journal of Clinical Endocrinology and Metabolism (2010 - 2014) Associate Editor

  • American College of Physicians (2010 - 2012) Book Editor, MKSAP 16/Endocrinology & Metabolism module

  • American Heart Association (2010 - 2012) Council on Nutrition, Physical Activity and Metabolism

  • Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (2010) Technical Expert Panel, Comparative Effectiveness and Safety of Diabetes Medications for Adults with Type 2 Diabetes

  • Duke Clinical Research Institute/Tethys Bioscience (2010 - Present) Executive Committee, PREVAIL National Quality Improvement Initiative

  • American Diabetes Association (2009 - 2011) Professional Practice Committee

  • Takeda Pharmaceuticals (2008 - 2009) Steering Committee, Prevention of Progression Study

  • Diabetes Care (2007 - 2010) Editorial Board

  • American College of Physicians (2007 - 2009) Member of Editorial Board for MKSAP 15/Endocrinology & Metabolism module

  • American Diabetes Association (2007 - 2008) Professional Practice Committee

  • American Association of Clinical Endocrinologists (AACE) (2007 - Present) Advisory Member for Task Force on Inpatient Diabetes & Glycemic Control

  • AmeriCares (2007 - Present) Global Medical Advisory Board

  • Joint Commission on Accreditation of Hospital Organizations (JCAHO) (2006) Hospital Diabetes Care Recognition Program Committee

  • American Association for Clinical Endocrinologists (AACE)-American Diabetes Association (ADA) (2006) Co-Chair of Consensus Development Conference: Improving Inpatient Diabetes Care: A Call to Action, Washington, D.C.

  • Diabetes & Vascular Disease Research (2006 - Present) Assistant Editor

  • Hormone Foundation (Endocrine Society) (2006 - Present) Diabetes Task Force

  • Association of Family Medicine Residency Directors (2005 - 2009) Frontline: Diabetes Workshop

  • American College of Physicians (2005 - 2006) Internal Medicine In-Training Examination Committee

  • Novartis (2004 - 2009) LAF237A/Vildagliptin Internal Medicine Safety Committee

  • American Diabetes Association (2004 - 2007) Member of Editorial Board for D.O.C. News, a primary care newsletter of the American Diabetes Association.

  • American College of Physicians (2004 - 2006) Member of Editorial Board for MKSAP 14/Endocrinology & Metabolism module

  • National Diabetes Education Initiative (2004 - Present) Co-editor of Clinical Insights in Diabetes (newsletter)

  • American Diabetes Association (2003 - 2004) Scientific and Medical Meetings Planning Committee

  • National Diabetes Education Initiative (2003 - Present) Education Council

  • Practical Diabetology (2002 - 2007) Associate Editor

  • American College of Physicians (2002 - 2004) Editorial Board, MKSAP 13/Endocrinology & Metabolism module

  • American Diabetes Association (2000 - 2001) Scientific and Medical Meetings Oversight Committee

  • American Diabetes Association (2000) Cardiovascular Disease Initiative

  • European Association for the Study of Diabetes (2000 - Present) Member

  • American College of Physicians (1998 - 2001) Physicians' Information and Education Resource (PIER) Project ("Osteoporosis")

  • Yale-New Haven Hospital I.H.I Quality Improvement in Diabetes Project (1998 - 2000) Member

  • Yale Faculty Practice (1998 - 1999) IDX Implementation Committee

  • Yale-New Haven Hospital Diabetes Critical Pathway Committee (1998) Member

  • Yale-New Haven Hospital DKA Critical Pathway Committee (1997) Chairperson

  • National Diabetes Education Initiative (1997 - Present) Member

  • Yale Faculty Practice (1996 - 1998) Credentialing Committee

  • Dana 3 Advisory Group (1996 - 1998) Member

  • American College of Physicians (1996 - 1998) Editorial Board, MKSAP 11/Endocrinology & Metabolism module

  • Yale Faculty Practice (1996 - 1997) Clinic Chiefs Finance Committee

  • Yale Clinical Practice Group (1996 - 1997) Care Management Committee

  • YNHH General Medical Practice Council (1996) Member

  • University Hospital Consortium Diabetes Project (1996 - Present) Consultant

  • The Endocrine Society (1996 - Present) Member

  • American Diabetes Association (1996 - Present) Member

  • TimeLife Medical (1995) Editorial Board, "Diabetes (At Time Of Diagnosis)" video program

  • Yale Primary Care Internship (1991 - 1995) Member of Selection Committee

Edit this profile

Contact Info

Silvio E Inzucchi, MD
Patient Care Locations
Yale EndocrinologySmilow Cancer Hospital at Yale New Haven
35 Park Street, Ste 4th Floor Multispecialty Care Center

New Haven, CT 06511
View on map...
Yale Endocrinology & MetabolismYale New Haven Hospital
20 York Street

New Haven, CT 06510
View on map...
Yale Diabetes CenterDana Clinic Building
789 Howard Avenue, Ste 2nd Floor

New Haven, CT 06519
View on map...
Yale Endocrinology & MetabolismYale Health Center
55 Lock Street

New Haven, CT 06511
View on map...
Mailing Address
EndocrinologyPO Box 208020
333 Cedar Street

New Haven, CT 06520-8056